List of Contents

Virtual Care Market Size, Share, and Trends 2024 to 2034

The global virtual care market size was USD 11.49 billion in 2023, calculated at USD 15.19 billion in 2024 and is projected to surpass around USD 247.67 billion by 2034, expanding at a CAGR of 32.2% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 4515
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Virtual Care Market 

5.1. COVID-19 Landscape: Virtual Care Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Virtual Care Market, By Modality

8.1. Virtual Care Market, by Modality, 2024-2034

8.1.1. Real-time Virtual Health

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Remote Patient Monitoring

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Store and Forward

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Virtual Care Market, By Component

9.1. Virtual Care Market, by Component, 2024-2034

9.1.1. Services

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Hardware

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Software

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Virtual Care Market, By Delivery Mode 

10.1. Virtual Care Market, by Delivery Mode, 2024-2034

10.1.1. Web/App-based

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Cloud-based

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. On-premises

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Virtual Care Market, By End-user 

11.1. Virtual Care Market, by End-user, 2024-2034

11.1.1. Healthcare Providers

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Patients

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Employer Groups and Government Organizations

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Payers

11.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Virtual Care Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Modality (2021-2034)

12.1.2. Market Revenue and Forecast, by Component (2021-2034)

12.1.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.1.4. Market Revenue and Forecast, by End-user (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Modality (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.1.5.4. Market Revenue and Forecast, by End-user (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Modality (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.1.6.4. Market Revenue and Forecast, by End-user (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Modality (2021-2034)

12.2.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.2.4. Market Revenue and Forecast, by End-user (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Modality (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.2.5.4. Market Revenue and Forecast, by End-user (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Modality (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.2.6.4. Market Revenue and Forecast, by End-user (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Modality (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.2.7.4. Market Revenue and Forecast, by End-user (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Modality (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.2.8.4. Market Revenue and Forecast, by End-user (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Modality (2021-2034)

12.3.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.3.4. Market Revenue and Forecast, by End-user (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Modality (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.3.5.4. Market Revenue and Forecast, by End-user (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Modality (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.3.6.4. Market Revenue and Forecast, by End-user (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Modality (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.3.7.4. Market Revenue and Forecast, by End-user (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Modality (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.3.8.4. Market Revenue and Forecast, by End-user (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Modality (2021-2034)

12.4.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.4.4. Market Revenue and Forecast, by End-user (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Modality (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.4.5.4. Market Revenue and Forecast, by End-user (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Modality (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.4.6.4. Market Revenue and Forecast, by End-user (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Modality (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.4.7.4. Market Revenue and Forecast, by End-user (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Modality (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.4.8.4. Market Revenue and Forecast, by End-user (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Modality (2021-2034)

12.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.5.4. Market Revenue and Forecast, by End-user (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Modality (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.5.5.4. Market Revenue and Forecast, by End-user (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Modality (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)

12.5.6.4. Market Revenue and Forecast, by End-user (2021-2034)

Chapter 13. Company Profiles

13.1. AMD Global Telemedicine

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. American Well

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. BioTelemetry

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. GlobalMedia Group

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Koninklijke Philips

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Resideo Life Care Solutions

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Medtronic

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Teladoc Health

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. InTouch Technologies

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Vivify Health

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client